Background. Chronic myeloid leukemia is a hematological malignancy caused by expression of BCR-ABL tyrosine kinase oncogene, product of the t(9;22) Philadelphia translocation. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.